U.S. Markets closed

Zalicus grantes patent covering formulations of Z160

Zalicus announced that it has been granted a patent by the U.S. Patent and Trademark office, or USPTO, covering novel formulations of its product candidate Z160. U.S. patent number 8,409,560, entitled "Solid Dispersion Formulations and Methods of Use Thereof," provides broad coverage for a range of novel Z160 pharmaceutical compositions and methods of using these compositions in the treatment of pain.